Involvement of the serotonin system in the antidepressant response;Le systeme a serotonine et la reponse antidepressive

Medecine/Sciences

Volumn 13, Issue 4, 1997, Pages 519-526

  Blier, Pierre ^a   De Montigny, Claude ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; MONOAMINE OXIDASE INHIBITOR; PINDOLOL; SEROTONIN; SEROTONIN 1A RECEPTOR; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

DEPRESSION; DRUG MECHANISM; ELECTROCONVULSIVE THERAPY; HUMAN; RECEPTOR DOWN REGULATION; REVIEW; SEROTONINERGIC SYSTEM;

ANIMALIA;

EID: 0031004388     PISSN: 07670974     EISSN: None     Source Type: Journal    
DOI: 10.4267/10608/407     Document Type: Review

References (31)

1. Selikoff I, Robityck EH, Ornstein GG. Toxicity of hydrazine derivatives of isonicotinic acid in chemotherapy of human tuberculosis. Quart Bull Seaview Hosp 1952; 13: 17-26.
2. Kuhn R. The treatment of depressive states with G22355 (imipramine hydrochloride). Am J Psyhiatr 1958; 115: 450-64.
3. Angst J. How recurrent and predictable is depressive illness? In: Montgomery S, Rouillon F, eds. Perspectives in psychiatry. Chichester: Wiley, 1992: 1-13.
4. Montgomery SA. Selective serotonin reuptake inhibitors in the acute treatment of depression. In: Bloom FE, Kupfer DJ eds. Psychopharmacology: the fourth generation of progress. Raven Press, 1995: 1043-51.
5. Hyttel J. Citalopram-pharmacological profile of a specific serotonin uptake inhibitor with antidepressant activity. Prog Neuropsychopharmacol Biol Psychiatr 1982; 6: 277-95.
6. De Montigny C, Aghajanian GK. Tricyclic antidepressants: long term treatment increases responsivity of rat forebrain neurons to serotonin. Science 1978; 202; 1301-6.
7. Blier P, de Montigny C. Current advances and trends in the treatment of depression. Trends pharmacol Sci 1994; 15: 220-6.
8. de Montigny C. Electroconvulsive shock treatments enhance responsiveness of fore-brain neurons to serotonin. J pharmacol Exp Ther 1984; 228: 230-4.
9. Charney DS, Heninger GR, Sternberg DE. Serotonin function and mechanism of action of antidepressant treatment. Effects of amitriptyline and desipramine. Arch Gen Psychiatr 1984; 41: 359-65.
10. de Montigny C, Grunberg F, Mayer A, Deschesne JP. Lithium induces rapid relief of depression in tricyclic antidepressant drug non-responders. Br J Psychiatry 1981; 138: 252-6.
11. de Montigny C. Lithium addition in treatment-resistant depression. Int Clin Psychopharmacol 1994; 9: 31-5.
12. Aghajanian GK, Graham AW, Sheard MH. Serotonin-containing neurons in brain: depression of firing by monamine oxidase inhibitors. Science 1972; 169: 1100-2.
13. Blier P, de Montigny C. Serotonergic but not noradrenergic neurons in rat CNS adapt to long-term treatment with inonoamine oxidase inhibitors. Neuroscience 1985; 16: 949-55.
14. Blier P, de Montigny C. Electrophysiological studies on the effect of repeated zimelidine administration on serotonergic neurotransmission in the rat. J Neurosci 1983; 3: 1270-8.
15. Chaput Y, de Montigny C, Blier P. Effects of a selective 5-HT reuptake blocker, citalopram, on the sensitivity of 5-HT auto-receptors: Electrophysiological studies in the rat. Naunyn Schmiedebergs Arch Pharmacol 1986; 333: 342-8.
16. Delgado PL, Charney DS, Price LH, Aghajanian GK, Landis H, Heninger GR. Serotonin function and the mechanism of antidepressant action: Reversal of antidepressant-induced remission by rapid depletion of plasma tryptophan. Arch Gen Psychiatr 1990; 47: 411-8.
17. Leyton M, Young SN, Blier P, Ellenbogen M, Palmour RM, Ghadirian M, Benkelfat C. The effect of tryptophan-depletion on mood in fully remitted, medication-free major affective disorder patients. Am Coll Neuropharmacol 1995; 34: 245.
18. de Montigny C, Chaput Y, Blier P. Classical and novel targets for antidepressant drugs. Int Acad Biomed Drug Res 1993; 5: 8-17.
19. 1A receptors in the dorsal raphe and hippocampus: I. Effect of spiperone. J Pharmacol Exp Ther 1993; 265: 7-15.
20. 1A receptors: in vivo microdialysis and electrophysiological studies in the rat brain. Neuropsychopharmacology 1997; 15: 349-60.
21. Artigas F, Perez V, Alvarez E. Pindolol induces a rapid improvement of depressed patients with serotonin reuptake inhititors. Arch Gen Psychiatr 1994; 51: 248-51.
22. Blier P, Bergeron R. Effectiveness of pindolol with selected antidepressant drugs in the treatment of major depression. J Clin Psychopharmacol 1995; 15: 217-22.
23. Isaac MT, Tome MB, Harte R. Serotonergic autoreceptor blockade in the reduction of antidepressant latency: a controlled trial. Am Psych Ass Abstr 1996; 149: 54.
24. 1A antagonists. Trends Neurosci 1996; 19: 378-83.
25. 1A partial agonists in depression: a composite analysis of buspirone in the treatment of depression. J Clin Psychopharmacol 1990; 10: 67S-76S.
26. 1A receptors produces a rapid antidepressant response. Neuropsychopharmacology 1997 (sous presse).
27. Galzin AM, Langer SZ. Modulation of 5-HT release by presynaptic inhibitory and facilitatory 5-HT receptors in brain slices. Adv Biosci 1991; 59-62.
28. IDautoreceptors on the modulation of 5-HT release in guinea-pig mesencephalic raphe, hippocampus and frontal cortex. Br J Pharmacol 1996; 118: 681-9.
29. Fineberg NA, Bullock T, Montgomery DB, Montgomery SA. Serotonin reuptake inhibitors are the treatment of choice in obsessive compulsive disorder. Int Clin Psychopharmacol 1992; 7: 43-7.
30. Blier P, Bouchard C. Modulation of serotonin release in the guinea pig brain following long-term administration of antidepressant drugs. Br J Pharmacol 1994; 113: 485-95.
31. El Mansari M, Bouchard C, Blier P. Alteration of serotonin release in the guinea pig orbitofrontal cortex: relevance to the treatment of obsessive compulsive disorder. Neuropsychopharmacolog 1995; 13: 117-27.